News
- Takayuki Yoshino, chairman of 22CEMIT, has been appointed as deputy director (Research) of the National Cancer Center Hospital East.
- Takayuki Yoshino spoke at the LDP's special committee!
- Dr. Takemasa, Director of 22 CEMIT, appeared on TV program, "The HUMAN - Envolving Surgeon"
- The 8th Opinion Exchange Meeting on the Forefront of Industry-Government-Academia Cancer Genome Medicine will be held! (Saturday, May 7, 2022 09:00-13:00)
- Dr. Yoshino, chairman of 22CEMIT, appeared on TV program, "Kyou-no-Kenko (Health Today)".
- Dr. Yoshino, chairman of 22CEMIT, was nominated as the first Japanese member of the Executive Board, which oversees ICGC-ARGO.
- The 1st Cancer CRC Study Group Meeting will be held.
- The 6th Opinion Exchange Meeting on the Forefront of Industry-Government-Academia Cancer Genome Medicine was held.
- Dr. Yoshino, chairman of 22CEMIT and Chief of Gastrointestinal Medicine at National Cancer Center East Hospital, has been introduced in a special program on TV Tokyo and BS TV Tokyo on his efforts in cutting-edge cancer treatment.
- CIRCULATE-Japan project led by Dr. Yoshino, chairman of 22CEMIT and Chief of Gastrointestinal Medicine at National Cancer Center East Hospital, was introduced in Shukan Shincho.
- The 5th Opinion Exchange Meeting on the Forefront of Industry-Government-Academia Cancer Genome Medicine was held.
- Research paper by the research group led by Dr. Yoshino, chairman of 22CEMIT, was published in "Nature Medicine".
- Dr.Yoshino, chairman of 22CEMIT, has started the world's largest investigator-initiated trial.
- Interview featuring Dr.Yoshino, chairman of 22CEMIT, has been published in Microsoft's medical website.
- Interview featuring Dr. Yoshino, chairman of 22CEMIT, has been published in BEST DOCTORS IN JAPAN.
- The technology developed by Natera Inc "To judge the possibility of cancer recurrence at 90% accuracy" has been invterviewd by TV Asahi Corporation.
- Cancer Genomic Medical Online Course is now available at Docomo gacco
- Dr. Kentaro Yamazaki, director of 22CEMIT, has received the Annals of Oncology Award 2019.
- 22CEMIT cooperated in publishing “Handbook of Hereditary Cancer” (published from KANEHARA & CO., LTD. )
- 22CEMIT Chairman & CEO, Takayuki Yoshino, spoke at Google Cloud Next ’19 | San Francisco on “Virtual Sequencing”.
- National Cancer Center Hospital East transferred management of ”e-Precision Medicine Japan” educational website to 22CEMIT.
- 22CEMIT hosted a VR conference of oncologists.
English 
Japanese